BIOCON LTD. - 532523 - Announcement Under Regulation 30
Investor Meeting02-04-2024
BIOCON LTD. - 532523 - Announcement Under Regulation 30
Biocon Biologics Limited, subsidiary of Biocon Limited, has completed the transaction of transfer of its branded formulations business in India to Eris Lifesciences Limited on a slump sale basis.02-04-2024
BIOCON LTD. - 532523 - Closure of Trading Window
Closure of trading window from Monday, April 1, 2024 until 48 hours after declaration of the financial results of the Company for the quarter and year ended March 31, 2024.28-03-2024
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Revised Press Release27-03-2024
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release27-03-2024
BIOCON LTD. - 532523 - Meeting Conducted With Institutional Investors/Research Analysts.
Meeting conducted with Institutional Investor/ Research Analyst25-03-2024
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Ad of postal ballot Notice23-03-2024
BIOCON LTD. - 532523 - Announcement Under Regulation 30 Of SEBI LODR Regulations.
Announcement under Regulation 30 of SEBI LODR Regulations.22-03-2024
BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice21-03-2024